SCHEMBL980074

SCHEMBL980074

CN(C)CCCc1[c]cccc1CC(=O)N1CCC(c2cc(Cl)ccc2Cl)=N1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 1/20 0.44
ORAI1 Q96D31 1/20 0.33
CCR3 P51677 2/20 0.33
KDM4E B2RXH2 2/20 0.32
ALDH1A1 P00352 2/20 0.32
GAA P10253 2/20 0.31
S1PR2 O95136 1/20 0.31
LMNA P02545 1/20 0.31
GLA P06280 1/20 0.31
MAPT P10636 1/20 0.31
HPGD P15428 1/20 0.31
HTT P42858 1/20 0.31
KMT2A Q03164 1/20 0.31
ATM Q13315 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2D6 P10635 1/20 0.31
ERCC1 P07992 1/20 0.30
ERCC4 Q92889 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL980746 0.85 KIF11 (0.42)
SCHEMBL982312 0.81 MAOB (0.39) METCCR3KDM4EALDH1A1GAA
SCHEMBL980138 0.80 HCRTR1 (0.35) METKDM4EALDH1A1HPGD
SCHEMBL5050486 0.73 MET (0.51) METORAI1ALDH1A1LMNAMAPT
SCHEMBL13580043 0.70 MET (0.58) METORAI1KDM4EALDH1A1LMNA
SCHEMBL981265 0.70 KIF11 (0.45) METALDH1A1KMT2A
SCHEMBL983930 0.68 MET (0.58) METORAI1ALDH1A1LMNAATM
SCHEMBL1427173 0.68 MET (0.58) METORAI1KDM4EALDH1A1LMNA
SCHEMBL982217 0.66 MET (0.67) METORAI1KDM4EALDH1A1GAA
SCHEMBL1427200 0.66 MET (0.53) METORAI1ALDH1A1LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7875644-B2 tyrosine kinase inhibitors, in particular Met kinase; antitumor agents;1-(Benzo-1,2,5-thiadiazol-5-ylmethylcarbonyl)-3-(2,4-dimethoxyphenyl)-4,5-dihydro-1H-pyrazole; leukemia, carcinomas MERCK PATENT GMBH (DE) 2011-01-25 US claimed